Advertisement

Aetna's profit jumps 17% on lower medical costs

By Bob Herman  |  April 28, 2015

Aetna beat earnings estimates and recorded $777.5 million of profit in the first quarter this year, prompting the Hartford, Conn.-based health insurer to raise profit predictions for the rest of the year.

Trinity Health, New York hospital try again for a deal

Trinity Health, New York hospital try again for a deal

By Melanie Evans  |  April 28, 2015

Trinity Health, Livonia, Mich., struck a definitive agreement to acquire St. Joseph's Hospital Health Center in Syracuse, N.Y. The health system previously negotiated with the New York hospital but failed to reach a deal.

Care-transition fumbles highlight CMS' reform challenges

Care-transition fumbles highlight CMS' reform challenges

By Melanie Evans  |  April 28, 2015

A CMS evaluation of community agencies' efforts to reduce hospital readmissions found that few succeeded. Critics of the evaluations and resulting contract terminations say the agency relied on unrealistic targets and flawed measures.

Population Health Management discussion and breakfast event

April 28, 2015

Join us in Detroit on May 7 for breakfast and a panel discussion on population health management with Joe Mullany, CEO, Detroit Medical Center; Dr. Bruce Muma, CMO, Henry Ford Physician Network; and Dr. Thomas Simmer, SVP and CMO, Blue Cross and Blue Shield of Michigan. Learn more and sign up today.

Covance acquisition complicates LabCorp's first quarter

By Adam Rubenfire  |  April 27, 2015

Acquisitions, restructuring and rising interest expenses left Laboratory Corporation of America Holdings with falling income despite slightly higher revenue in its first quarter.

Top 25 Women in Healthcare Honorees Leading Change

Top 25 Women in Healthcare Honorees Leading Change

April 27, 2015

Chicago, IL – Modern Healthcare is proud to announce the 2015 Top Women in Healthcare. In its sixth year, the biennial recognition program honors female healthcare executives who are developing policy, leading...

Mylan rejects Teva's $40.1 billion buyout bid

By Associated Press  |  April 27, 2015

Mylan rejected Teva Pharmaceuticals' $40.1 billion buyout offer, saying the cash-and-stock proposal undervalues the company. The rejection comes as both Mylan and Teva look to further consolidate an increasingly competitive generic drug industry.

Advertisement
Modern Healthcare Daily

The top stories in healthcare business every day

The Modern Healthcare Daily News App provides you with registration-free access to the top trending healthcare business news. It's the only news you need each day.